IDEXX Laboratories Inc. (Nasdaq: IDXX) has developed a diagnostic test to help veterinarians detect kidney injury in cats and dogs at an earlier stage to improve treatment. The Westbrook-based ...
In early April 2026, IDEXX Laboratories expanded its IDEXX Cancer Dx Panel to the UK, offering veterinarians a £22.50 blood test that can detect canine lymphoma up to eight months before clinical ...
IDEXX Laboratories, Inc. IDXX recently launched the Catalyst Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis. With the innovative load-and-go ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Helping clinicians investigate sooner and plan next steps with confidence ...
IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the 9 Best QQQ Stocks to Buy Now. On April 01, IDEXX Laboratories announced the launch of the IDEXX Cancer Dx Panel in the UK, specifically for the ...
Zacks Investment Research on MSN
IDEXX Laboratories stock up 39.4% in a year: What's driving it?
Shares of IDEXX Laboratories IDXX have rallied 39.1% over the past 12 months, showing impressive momentum. The stock has outpaced its industry, which rose 2.3%, as well as the S&P 500 Composite’s 29.6 ...
IDEXX Laboratories is a leader in animal diagnostics, boasting strong recurring revenue and nearly 50% stock gains year-to-date. IDXX's innovation pipeline, robust cash position, and global reach ...
While they might not represent the most exciting field in the biotech space, animal healthcare companies have been a steady, consistent source of growth in what's often a turbulent market. One company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results